Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CSPC Zhongnuo Pharmaceutical is a core subsidiary of the CSPC Pharmaceutical Group, serving as one of China's largest production bases for antibiotics and finished drug preparations. The company specializes in the research, development, and large-scale manufacturing of a wide range of pharmaceuticals, including penicillin, cephalosporins, and cardiovascular medications. With a strong focus on both active pharmaceutical ingredients (APIs) and finished dosage forms, CSPC Zhongnuo plays a critical role in the group's supply chain and global export strategy. Its product portfolio includes well-known brands in the Chinese market, particularly in the fields of anti-infectives and chronic disease management. The company operates multiple GMP-certified facilities and is a major contributor to the parent group's industrial leadership in the chemical drug sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CSPC Zhongnuo Pharmaceutical Technology.